Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy.

Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy.

[Anonymous].  2018.  Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy.. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 202:187-195.

MicroRNA-30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2.

MicroRNA-30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2.

[Anonymous].  2018.  MicroRNA-30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 104:411-419.

Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.

Treatment effects measured by restricted mean survival time in trials of immune checkpoint inhibitors for cancer.

Correlation of increased corrected TIMI frame counts and the topographical extent of isolated coronary artery ectasia.

NPBSS: a new PacBio sequencing simulator for generating the continuous long reads with an empirical model.

Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective...

Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective...

[Anonymous].  2018.  Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective.... Cancer communications (London, England). 38(1):28.

Systematic evaluation of a <sup>171</sup>Yb optical clock by synchronous comparison between two lattice systems.

The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses.

SO<sub>2</sub> absorption in EmimCl-TEG deep eutectic solvents.